{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T06:04:16Z","timestamp":1745906656128,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10388-021-00889-z","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T19:44:00Z","timestamp":1634327040000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Determinants of reflux perception in patients with non-erosive reflux disease who have reflux-related symptoms on potassium-competitive acid blocker therapy"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-8399","authenticated-orcid":false,"given":"Noriyuki","family":"Kawami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Koeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Momma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/gut.2005.074690","volume":"55","author":"AJ Bredenoord","year":"2006","unstructured":"Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut. 2006;55:313\u20138.","journal-title":"Gut"},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gut.2007.133470","volume":"57","author":"F Zerbib","year":"2008","unstructured":"Zerbib F, Duriez A, Roman S, et al. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut. 2008;57:156\u201360.","journal-title":"Gut"},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1572-0241.2008.01791.x","volume":"103","author":"R Tutuian","year":"2008","unstructured":"Tutuian R, Vela MF, Hill EG, et al. Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol. 2008;103:1090\u20136.","journal-title":"Am J Gastroenterol"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000309483","volume":"82","author":"K Iwakiri","year":"2010","unstructured":"Iwakiri K, Sano H, Tanaka Y, et al. Characteristics of symptomatic reflux episodes in patients with non-erosive reflux disease who have a positive symptom index on proton pump inhibitor therapy. Digestion. 2010;82:156\u201361.","journal-title":"Digestion"},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1365-2982.2009.01355.x","volume":"21","author":"M Cicala","year":"2009","unstructured":"Cicala M, Habib FI, Emerenziani S. Proximal oesophagus: the added value in understanding GORD symptoms. Neurogastroenterol Motil. 2009;21:790\u20135.","journal-title":"Neurogastroenterol Motil"},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1159\/000500133","volume":"101","author":"Y Abe","year":"2020","unstructured":"Abe Y, Koike T, Saito M, et al. Influence of the pH value of refluxate and proximal extent on heartburn perception in patients with proton pump inhibitor-refractory non-erosive reflux disease. Digestion. 2020;101:375\u201381.","journal-title":"Digestion"},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/apt.13121","volume":"41","author":"H Jenkins","year":"2015","unstructured":"Jenkins H, Sakurai Y, Nishimura A, et al. Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects. Aliment Pharmacol Ther. 2015;41:636\u201348.","journal-title":"Aliment Pharmacol Ther"},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2013a randomised open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"889_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000456072","volume":"95","author":"S Hoshino","year":"2017","unstructured":"Hoshino S, Kawami N, Takenouchi N, et al. Efficacy of vonoprazan for proton pump inhibitor-resistant reflux esophagitis. Digestion. 2017;95:156\u201361.","journal-title":"Digestion"},{"key":"889_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000488530","volume":"98","author":"N Kawami","year":"2018","unstructured":"Kawami N, Hoshino S, Hoshikawa Y, et al. Pathogenesis of potassium-competitive acid blocker-resistant non-erosive reflux disease. Digestion. 2018;98:194\u2013200.","journal-title":"Digestion"},{"key":"889_CR11","doi-asserted-by":"crossref","first-page":"e14058","DOI":"10.1111\/nmo.14058","volume":"33","author":"R Yadlapati","year":"2021","unstructured":"Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0(\u00a9). Neurogastroenterol Motil. 2021;33:e14058.","journal-title":"Neurogastroenterol Motil"},{"key":"889_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/nmo.12446","volume":"27","author":"S Kuribayashi","year":"2015","unstructured":"Kuribayashi S, Iwakiri K, Kawada A, et al. Variant parameter values-as defined by the Chicago criteria-produced by ManoScan and a new system with Unisensor catheter. Neurogastroenterol Motil. 2015;27:188\u201394.","journal-title":"Neurogastroenterol Motil"},{"key":"889_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s00535-019-01608-3","volume":"54","author":"S Kuribayashi","year":"2019","unstructured":"Kuribayashi S, Iwakiri K, Shinozaki T, et al. Clinical impact of different cut-off values in high-resolution manometry systems on diagnosing esophageal motility disorders. J Gastroenterol. 2019;54:1078\u201382.","journal-title":"J Gastroenterol"},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1572-0241.2006.00711.x","volume":"101","author":"F Zerbib","year":"2006","unstructured":"Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006;101:1956\u201363.","journal-title":"Am J Gastroenterol"},{"key":"889_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1136\/gut.2003.033290","volume":"53","author":"D Sifrim","year":"2004","unstructured":"Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024\u201331.","journal-title":"Gut"},{"key":"889_CR16","first-page":"358","volume":"83","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358\u201361.","journal-title":"Am J Gastroenterol"},{"key":"889_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2036.2007.03281.x","volume":"25","author":"D Sifrim","year":"2007","unstructured":"Sifrim D, Mittal R, Fass R, et al. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007;25:1003\u201317.","journal-title":"Aliment Pharmacol Ther"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0016-5085(98)70014-9","volume":"115","author":"R Fass","year":"1998","unstructured":"Fass R, Naliboff B, Higa L, et al. Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology. 1998;115:1363\u201373.","journal-title":"Gastroenterology"},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"G130","DOI":"10.1152\/ajpgi.00388.2007","volume":"294","author":"K Bielefeldt","year":"2008","unstructured":"Bielefeldt K, Davis BM. Differential effects of ASIC3 and TRPV1 deletion on gastroesophageal sensation in mice. Am J Physiol Gastrointest Liver Physiol. 2008;294:G130\u20138.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Pt 2","key":"889_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1469-7793.2000.00403.x","volume":"523","author":"AJ Page","year":"2000","unstructured":"Page AJ, O\u2019Donnell TA, Blackshaw LA. P2X purinoceptor-induced sensitization of ferret vagal mechanoreceptors in oesophageal inflammation. J Physiol. 2000;523(Pt 2):403\u201311.","journal-title":"J Physiol"},{"key":"889_CR21","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1136\/gut.2005.071084","volume":"54","author":"AJ Page","year":"2005","unstructured":"Page AJ, Brierley SM, Martin CM, et al. Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. Gut. 2005;54:1408\u201315.","journal-title":"Gut"},{"key":"889_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5056\/jnm.2010.16.4.353","volume":"16","author":"H Miwa","year":"2010","unstructured":"Miwa H, Kondo T, Oshima T, et al. Esophageal sensation and esophageal hypersensitivity-overview from bench to bedside. J Neurogastroenterol Motil. 2010;16:353\u201362.","journal-title":"J Neurogastroenterol Motil"},{"key":"889_CR23","doi-asserted-by":"publisher","first-page":"746-e219","DOI":"10.1111\/j.1365-2982.2010.01514.x","volume":"22","author":"MP Guarino","year":"2010","unstructured":"Guarino MP, Cheng L, Ma J, et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil. 2010;22:746-e219-751.","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl 2","key":"889_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2036.2006.03038.x","volume":"24","author":"NB Roberts","year":"2006","unstructured":"Roberts NB. Review article: human pepsins-their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther. 2006;24(Suppl 2):2\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"889_CR25","first-page":"477","volume":"102","author":"GW Kidder 3rd","year":"1983","unstructured":"Kidder GW 3rd, Lillemoe KD, Harmon JW, et al. Evaluation of in vivo measurement of transesophageal electrical resistance as an indicator of early experimental esophageal mucosal injury. J Lab Clin Med. 1983;102:477\u201386.","journal-title":"J Lab Clin Med"},{"key":"889_CR26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/nmo.12201","volume":"25","author":"R Farr\u00e9","year":"2013","unstructured":"Farr\u00e9 R. Pathophysiology of gastro-esophageal reflux disease: a role for mucosa integrity? Neurogastroenterol Motil. 2013;25:783\u201399.","journal-title":"Neurogastroenterol Motil"},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10388-021-00825-1","volume":"18","author":"T Tanabe","year":"2021","unstructured":"Tanabe T, Koeda M, Kitasako Y, et al. Stimulated saliva secretion is reduced in proton pump inhibitor-resistant severe reflux esophagitis patients. Esophagus. 2021;18:676\u201383.","journal-title":"Esophagus"},{"key":"889_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-021-00845-x","author":"M Koeda","year":"2021","unstructured":"Koeda M, Tanabe T, Kitasako Y, et al. Saliva secretion is reduced in proton pump inhibitor-responsive non-erosive reflux disease patients. Esophagus. 2021. https:\/\/doi.org\/10.1007\/s10388-021-00845-x (Online ahead of print).","journal-title":"Esophagus"},{"key":"889_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-021-00880-8","author":"M Koeda","year":"2021","unstructured":"Koeda M, Tanabe T, Kitasako Y, et al. Saliva secretion is reduced in mild reflux esophagitis patients. Esophagus. 2021. https:\/\/doi.org\/10.1007\/s10388-021-00880-8 (Online ahead of print).","journal-title":"Esophagus"}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-021-00889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10388-021-00889-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-021-00889-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:11:20Z","timestamp":1699686680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10388-021-00889-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1007\/s10388-021-00889-z","relation":{},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"type":"print","value":"1612-9059"},{"type":"electronic","value":"1612-9067"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"Dr. Iwakiri received research grants from Otsuka Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd., as well as lecture fees from Otsuka Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. There are no other conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This was a retrospective study; thus, consent to participate was obtained using an opt-out method.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}